If you think your creditworthiness is determined by CIBIL score alone, think again. Apart from the CIBIL score that banks and NBFC take into account for lending purpose, alternate credit scoring models have come up of late that are factored in for determining the creditworthiness of an individual.

Health insurance policies come with restoration and recharge benefits, but not many policyholders know what these benefits entail or can tell the difference between the two.  So, let us try to find out various kinds of restoration options, how recharge benefits the insured and the difference between restoration and recharge benefits.

You must be aware of the divestment plans of the Government of India, wherein the government has divested its stake in various public sector undertakings (PSUs) and has thereby raised money from the markets.  The aim of the government’s divestment is to augments its revenue for the purpose of development.

The Reserve Bank of India deputy governor Viral Acharya has said that the Prompt Corrective Action (PCA) taken by the central bank against 11 public sector banks and one private bank has limited the losses of these banks and saved taxpayers’ money.

The stocks most likely to witness significant movement on the bourses on October 15, 2018 are Voltas Limited, Karnataka Bank Ltd., 3i Infotech, Tata Sponge Iron and Hindustan Unilever Limited. 

RajCOMP Info Services, a Govt of Rajasthan Undertaking has awarded a Letter Of Intent (LoI) to ITI Limited to execute RajNet project.

Major auto stock were buzzing as SIAM released sales data for the six months ending September. Domestic automobile sector registered 7.97 per cent growth in the production of vehicles from April-September period.

Ahead of its second-quarter results, the stock of Tata Sponge Iron was trading at a positive mark. The stock which opened at Rs. 815 per share went up by almost 10 per cent from its previous close to touch intraday high of Rs. 894.6 crore.

Hindustan Unilever is expected to report Q2FY19 results post market hours on Friday and thereby the stock is trading up 2.5 per cent ahead of the results. We hold 1620-1650 as the resistance provided stock closes above 1575 mark. On the downside, 1520 followed by 1475 will act as supports. 

Global Pharmaceutical company Zydus Cadila has received the tentative approval from the USFDA to market Linagliptin and Metformin HydrochlorideTablets. The tablets will be manufactured in Ahmedabad, India.